Skip to main content
. Author manuscript; available in PMC: 2023 Aug 16.
Published in final edited form as: Gastroenterology. 2022 Feb 14;162(7):2004–2017.e2. doi: 10.1053/j.gastro.2022.02.017

Figure 7.

Figure 7.

Schematic diagram of circANAPC7 suppressed tumor growth and muscle wasting through PHLPP2–AKT–TGF-β signaling axis in pancreatic cancer. This study identified circANAPC7 as a novel tumor suppressor, which functions through the CREB–miR-373–PHLPP2 axis, leading to AKT dephosphorylation and cyclin D1 and TGF-β down-regulation to suppress tumor progression in pancreatic cancer.